JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Surgical alternatives for hepatic hydatid disease.

BACKGROUND/AIMS: In this study we report on our method in the treatment of hepatic hydatid disease (HHD) and analyze the outcomes after minimal invasive surgery (MIS) and open surgery (OS). We evaluated the performance of MIS in patients with solitary HHD.

METHODOLOGY: In total 136 patients with HHD were operated on in our department, 69 of them underwent OS and the other 67 patients were treated with MIS. MIS is a combination of minimal incision laparotomy with laparoscopical video assistance. An specially developed device for cyst evacuation was used during MIS. All patients were followed-up for 6 months postoperatively.

RESULTS: The average duration of MIS surgery was of 67.5 ± 5min and for OS it was 98.6 ± 12.2min. The length of incision was 6.2 ± 1.1cm in MIS and 21.5 ± 2.5cm in OS. Hospital stay was 5.8 ± 1.4 days and recovery period 13.4 ± 2.1 days for patients after MIS, and 12.5 ± 2.1 days and 25.2 ± 2.6 days for patients after OS, respectively. Postoperative complications were observed more frequently in the OS group.

CONCLUSIONS: In suitable cases of HHD, MIS seems to be a good alternative to traditional OS for it is comparably safe and with a better postoperative outcome and a shorter postoperative rehabilitation period. Based on this experience we can advice MIS in selected patients with definitive indications.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app